Cysteine string protein and its role in neurodegenerative diseases
US7445904B2 · kind B2 · utility
Inventors
Key dates
| Filing date | Sep 26, 2002 |
| Grant date | Nov 4, 2008 |
| Priority date | — |
| Expiry date | Sep 26, 2022 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA01K2267/0318
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The present invention relates to in vitro and in vivo assays for the identification of agents that are useful in the treatment of neurodegenerative diseases that are associated with defects in protein folding. The present further relates to in vitro and in vivo assays for the identification of agents that contribute to the neurodegenerative processes which occur in these diseases. The present invention also relates to in vitro and in vivo models of neurodegenerative diseases. These assays and models will be useful in further understanding the pathogenesis of various neurodegenerative diseases in which defects in protein folding have been implicated, in identifying additional endogenous or environmental factors that contribute to the etiologies of these diseases, and in developing effective therapies for the prevention and/or treatment of these diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.